CJC-1295 No DAC / Ipamorelin

GH Optimization Blend

The most popular GH optimization combination — GHRH and GHRP working synergistically for maximum physiological GH release.

100% 50% · t½ Time → Serum level
Molecular Weight
—
Half-Life
Varies
Typical Dose
0.5 mg to 1.5 mg
Cycle Length
8–16 weeks

Description

The CJC-1295 No DAC / Ipamorelin combination is the most widely used GH optimization protocol. CJC-1295 No DAC provides the GHRH stimulus while Ipamorelin amplifies the GH pulse, producing synergistic GH release with physiological pulsatility.

Key Characteristics

Molecular WeightNot specified
Half-LifeVaries
Administration RoutesSubcutaneous injection
Typical Dose0.5 mg to 1.5 mg
Frequency2–3x daily
Cycle Length8–16 weeks

Investigated Benefits

  • Synergistic GH release (3–5x greater than either alone)
  • Improved body composition
  • Better sleep quality
  • Physiological GH pulsatility
  • Enhanced recovery
  • Increased IGF-1

* Benefits based on preclinical/animal research unless otherwise noted.